Company: MIRA
Filing Date: 2025-06-17
Form Type: 8-K
Source: 0001641172-25-015401
Chunk: 0

Company: MIRA PHARMACEUTICALS, INC.
Filing Date: 2025-06-17
Form: 8-K
Item: Item 8.01
Chunk 0
---
Item
8.01 Other Events

On
June 17, MIRA Pharmaceuticals, Inc. (the “ Company”) announced that its lead drug candidate, Ketamir-2 peer-reviewed journalFrontiers in Pharmacology

The
article, titled “ KETAMIR-2, A NEW MOLECULAR ENTITY AND NOVEL KETAMINE ANALOG,” Dr. Itzchak Angel Experimental Pharmacology and Drug Discovery

Key
highlights from the publication include:

  Selective,                                                                                                                                                        
  No                                                                                                                                                                
  Demonstrated                                                                                                                                                      
  Improved                                                                                                                                                          

The
Company also provided updates on its broader pipeline and clinical development progress:

  The                                                                                                                                 
  A Phase 2a trial in neuropathic pain is expected to initiate by year-end 2025, pending regulatory clearance.                        
  Additional scientific data submissions and presentations are planned throughout 2025.                                               
  MIRA                                                                                                                                

SIGNATURES

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

                     MIRA                                          
  Dated:             By:                        /s/                
                     Name:                      Erez               
                     Title:                     Chief